Dynamic morphology of the synaptic junctional areas during aging: the effect of chronic acetyl-L-carnitine administration Brain Res 1994
The FDA approved the first GLP-1 drug, exenatide, in 2005 for type 2 diabetes, according to the Cleveland Clinic
It's not a miracle Like none of these things are miracle, or superfoods or anything like that but it seems to be a scientifically supported option that works with our body's natural processes and I wouldn't fear it, just like I wouldn't fear pretty much any food at this point, and we're already seeing it in approved products
doi: 10.1056/NEJMoa1509225 98 HernandezAFGreenJBJanmohamedSDAgostinoRBSr.GrangerCBJonesNPet al
2024, health.osu.edu/wellness/exercise-and-nutrition/glp1-foods-to-limit#:~:text=Be%20careful%20if%20the%20volume,Recommended%20Read.
For brands and manufacturers developing endurance, fat-oxidation, or metabolic health products, carnitine offers broader formulation flexibility and compatibility with long-term use, positioning focused on mitochondrial energy pathways rather than acute performance buffering
